Skip to main content
Innate Pharma logo

Innate Pharma — Investor Relations & Filings

Ticker · IPH ISIN · FR0010331421 LEI · 9695002Y8420ZB8HJE29 PA Manufacturing
Open in API
Filings indexed 1,403 across all filing types
Latest filing 2025-04-30 Report Publication Anno…
Country FR France
Listing PA IPH

About Innate Pharma

http://www.innate-pharma.com/

Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.

Recent filings

Filing Released Lang Actions
Terms of availability of a registration document or its updates
Report Publication Announcement Classification · 1% confidence The document is a press release announcing the filing of the company's 2024 Universal Registration Document and 2024 Annual Report on Form 20-F. It provides links to where these reports can be accessed but does not contain the financial statements themselves. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA). FY 2024
2025-04-30 English
Modalités de mise à disposition de document de référence ou de ses actualisations
Report Publication Announcement Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and its primary purpose is to announce that two key annual documents have been filed: the 'Document d'enregistrement universel 2024' (Universal Registration Document) with the AMF, and the 'rapport annuel sur Form 20-F pour l'année 2024' with the SEC. The text states that these documents 'peut être consulté et téléchargé' (can be viewed and downloaded) from the company or regulatory websites. This structure—a short announcement directing the reader to the actual, comprehensive reports (which include the annual financial report and governance report)—perfectly matches the definition of a Report Publication Announcement (RPA). Although the content relates to annual reports (10-K equivalent), the document itself is the announcement of their publication, not the reports themselves. The length (6802 chars) is substantial for a simple press release but still functions as a notification wrapper.
2025-04-30 French
Document d'enregistrement universel 2024
Annual Report (ESEF) Classification · 1% confidence FY 2024
2025-04-30 French
20-F
Annual Report FY 2024
2025-04-30 English
6-K
Foreign Filer Report
2025-04-29 English
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release dated April 29, 2025, announcing the presentation of preclinical data for the drug candidate IPH4502 at the AACR 2025 Annual Meeting. It details scientific findings, mentions an ongoing Phase 1 clinical trial, and includes standard company boilerplate and forward-looking statements. This format—a formal announcement of scientific or operational news via press release—is characteristic of an Earnings Release (ER) if it were focused on financial results, or more generally, a Regulatory Filing (RNS) if it doesn't fit a more specific category. Since it is a scientific/clinical update rather than a financial results summary (ER) or a formal regulatory report (like 10-K or IR), and it is not a transcript (CT), presentation (IP), or management discussion (MDA), the most appropriate general category for a significant, non-financial corporate announcement that is not covered by other specific codes (like DIRS, DIV, CAP, etc.) is Regulatory Filings (RNS). It is not an announcement of a report publication (RPA) because it contains the substantive information itself, not just a notice that a report is available.
2025-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.